Biologics & New Modalities

peptidomimetic

A peptidomimetic is a molecule designed to copy the way a peptide grips its target, while replacing the fragile peptide parts with sturdier chemistry. Think of it as a stunt double that strikes the same pose as the original peptide but is built to survive the rough conditions inside the body.

Natural peptides are excellent at recognizing proteins, but they are rapidly digested by enzymes and rarely survive being swallowed. A peptidomimetic keeps the chemical groups that actually touch the target, the pharmacophore, but swaps in non-natural amino acids, altered backbone bonds, or ring constraints so the molecule resists breakdown, lasts longer, and may even be taken orally.

Peptidomimetics sit on a spectrum: some still look mostly like peptides, while others have been reworked so heavily they resemble small molecules. The design goal is always the same trade, keeping the binding strength and selectivity that make peptides attractive while gaining the stability and drug-like properties that peptides usually lack.

Many HIV protease inhibitors are peptidomimetics: they imitate the peptide the viral enzyme normally cuts, but use a stable bond the enzyme cannot break.

A molecule that mimics a peptide while resisting the enzymes that destroy peptides.

Replacing the breakable amide bond with a non-hydrolyzable mimic is a classic peptidomimetic strategy and a form of bioisosteric replacement.

Also called
peptide mimetic肽模拟物胜肽模擬物